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The aim of this work was to develop a new microparticulate system able to form a
complex with radionuclides with a high yield of purity for diagnostic or therapeutic
applications. Owing to its properties potato starch was chosen as starting material
and modified by oxidization and coupling of a ligand (polyamine) enabling modified
starch to chelate radionuclides. The choice of suitable experiments was based on a
combination of a Rechtschaffner experimental design and a surface response design
to determine the influence of experimental parameters and to optimize the final
product. Starch-based microparticle formulations from the experimental plans were
compared and characterized through particle size analysis, scanning electron
microscopy, elemental analysis and, for the most promising formulations, by in vitro
labeling stability studies and determination of free polyamine content or in vivo
imaging studies. The mechanism of starch-based microparticle degradation was
identified by means of size measurements. The results of the Rechtschaffner design
showed the positive qualitative effect of the temperature and the duration of
coupling reaction whereas surface response analysis clearly showed that, by
increasing the oxidization level and starch concentration, the nitrogen content in the
final product is increased. In vitro and in vivo characterization led to identification of
the best formulation. With a size around 30 mum, high radiochemical purity (over
95%) and a high signal-to-noise ratio (over 600), the new starch-based
microparticulate system could be prepared as ready-to-use kits and sterilized without
modification of its characteristics, and thus meet the requirement for in vivo
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